Differential role of the nitric oxide pathway on delta(9)-THC-induced central nervous system effects in the mouse.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 11168564)

Published in Eur J Neurosci on February 01, 2001

Authors

S C Azad1, G Marsicano, I Eberlein, J Putzke, W Zieglgänsberger, R Spanagel, B Lutz

Author Affiliations

1: Clinic for Anaesthesiology, Pain Treatment Unit, Ludwig-Maximilians-University, Munich, Germany. Shahnaz.Azad@lrz.uni-muenchen.de

Articles by these authors

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet (1998) 3.42

Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci (1999) 2.92

Neuropharmacology of alcohol addiction. Br J Pharmacol (2008) 2.65

The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry (2010) 2.23

Visualizing unstained neurons in living brain slices by infrared DIC-videomicroscopy. Brain Res (1990) 1.87

Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord (2003) 1.74

Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science (1979) 1.63

Actions of glutamic acid on spinal neurones. Exp Brain Res (1973) 1.61

Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry (2006) 1.59

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

The mechanism of inhibition of neuronal activity by opiates in the spinal cord of cat. Brain Res (1976) 1.56

[Risk assessment in pain therapy]. Schmerz (2008) 1.52

The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci (1993) 1.46

Region-specific encoding of sensory and affective components of pain in the human brain: a positron emission tomography correlation analysis. Ann Neurol (1999) 1.43

Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting. Nat Genet (1993) 1.43

Voltage dependence of excitatory postsynaptic potentials of rat neocortical neurons. J Neurophysiol (1991) 1.43

Activation kinetics and single channel properties of recombinant alpha1beta2gamma2L GABA(A) receptor channels. Neuroreport (1997) 1.41

[Back pain: guidelines for drug therapy. Utilize the therapeutic spectrum]. MMW Fortschr Med (2000) 1.40

Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience (2002) 1.37

Baclofen reduces post-synaptic potentials of rat cortical neurones by an action other than its hyperpolarizing action. J Physiol (1987) 1.34

A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. Br J Pharmacol (2010) 1.32

Microelectrophoretic studies concerning the spread of glutamic acid and GABA in brain tissue. Exp Brain Res (1969) 1.32

Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats. Behav Pharmacol (1998) 1.26

The orthologous human and murine semaphorin 6A-1 proteins (SEMA6A-1/Sema6A-1) bind to the enabled/vasodilator-stimulated phosphoprotein-like protein (EVL) via a novel carboxyl-terminal zyxin-like domain. J Biol Chem (2000) 1.24

Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2012) 1.23

Differential gene expression in peripheral blood of patients suffering from post-traumatic stress disorder. Mol Psychiatry (2007) 1.23

Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol (1996) 1.23

Neuromodulatory functions of the endocannabinoid system. J Endocrinol Invest (2006) 1.22

The endocannabinoid system in anxiety, fear memory and habituation. J Psychopharmacol (2011) 1.21

The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Lett (2001) 1.20

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19

Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76  TeV. Phys Rev Lett (2012) 1.19

Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci (1997) 1.19

Comparison of ceftizoxime and penicillin for the treatment of uncomplicated gonorrhoea. J Antimicrob Chemother (1982) 1.18

Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry (1996) 1.18

Progesterone receptor-mediated effects of neuroactive steroids. Neuron (1993) 1.18

NMDA and AMPA receptors on neocortical neurons are differentially distributed. Eur J Neurosci (1998) 1.14

Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Cell Mol Life Sci (2003) 1.12

Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans. J Infect Dis (1992) 1.12

Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats. Psychopharmacology (Berl) (2000) 1.10

Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7  TeV. Phys Rev Lett (2012) 1.10

Electrophoretic release of tritium-labelled glutamic acid from micropipettes in vitro. Brain Res (1969) 1.10

Distribution and developmental changes in metabotropic glutamate receptor messenger RNA expression in the rat lumbar spinal cord. Brain Res Dev Brain Res (1999) 1.09

Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09

Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav Pharmacol (2005) 1.09

Effects of opiates and methionine-enkephalin on pontine and bulbar respiratory neurones of the cat. Brain Res (1978) 1.08

Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08

Calcium reverses the inhibitory action of morphine on neuroeffector transmission in the mouse vas deferens. Brain Res (1980) 1.07

Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies. Glia (2000) 1.07

Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. Biophys J (2003) 1.06

Opioid receptors in the human cerebellum: evidence from [11C]diprenorphine PET, mRNA expression and autoradiography. Neuroreport (1999) 1.06

Synaptic plasticity in the basolateral amygdala in transgenic mice expressing dominant-negative cAMP response element-binding protein (CREB) in forebrain. Eur J Neurosci (2000) 1.05

The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. Neuropharmacology (2001) 1.05

Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05

Precisely localized LTD in the neocortex revealed by infrared-guided laser stimulation. Science (1999) 1.03

Isoflurane blocks synaptic plasticity in the mouse hippocampus. Anesthesiology (2001) 1.03

Expression of metabotropic glutamate receptor subtype mRNA (mGluR1-8) in human cerebellum. Neuroreport (1999) 1.02

Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon. Am J Physiol Gastrointest Liver Physiol (2003) 1.01

Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology (Berl) (1999) 1.00

Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience (2007) 1.00

Presynaptic and postsynaptic GABAB receptors of neocortical neurons of the rat in vitro: differences in pharmacology and ionic mechanisms. Synapse (1997) 1.00

Mature spinal ganglion cells are not sensitive to opiate receptor mediated actions. Neurosci Lett (1981) 0.99

Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission. Genes Brain Behav (2009) 0.99

Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate. Pharmacogenomics J (2010) 0.99

The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4. Neuroscience (2008) 0.98

Enkephalin-induced inhibition of cortical neurones and the lack of this effect in morphine tolerant/dependent rats. Brain Res (1976) 0.98

A cholinergic mechanism in the spinal cord of cats. Neuropharmacology (1974) 0.97

Metabolic activity changes in the rat spinal cord during adjuvant monoarthritis. Neuroscience (1999) 0.97

Alpha2-adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of Gi/o-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD. Eur J Neurosci (2003) 0.97

A method to discriminate axonal from cellbody activity and to analyse "silent cells". Exp Brain Res (1974) 0.96

Infrared videomicroscopy: a new look at neuronal structure and function. Trends Neurosci (1994) 0.96

The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice. Neurogastroenterol Motil (2008) 0.96

[3H]-nociceptin ligand-binding and nociceptin opioid receptor mrna expression in the human brain. Neuroscience (2003) 0.96

Effects of substance P on neurones in the dorsal horn of the spinal cord of the cat. Brain Res (1979) 0.96

Clinical evaluation of the therapeutic efficacy and tolerability of piperacillin. Antimicrob Agents Chemother (1982) 0.96

Postnatal development of cannabinoid receptor type 1 expression in rodent somatosensory cortex. Neuroscience (2007) 0.95

Measurement of associated production of vector bosons and top quark-antiquark pairs in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2013) 0.95

Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. Alcohol Clin Exp Res (1997) 0.95

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol Psychiatry (2003) 0.95

Search for dark matter and large extra dimensions in pp collisions yielding a photon and missing transverse energy. Phys Rev Lett (2012) 0.95

The distribution of splice variants of the NMDAR1 subunit mRNA in adult rat brain. Brain Res Mol Brain Res (1995) 0.94

Ethanol and N-methyl-D-aspartate receptor complex interactions: a detailed drug discrimination study in the rat. Psychopharmacology (Berl) (1998) 0.94

Glutamate receptors form hot spots on apical dendrites of neocortical pyramidal neurons. J Neurophysiol (2001) 0.93

Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Mol Psychiatry (2004) 0.93

Differential distribution of metabotropic glutamate receptor subtype mRNAs in the thalamus of the rat. Brain Res (2000) 0.92

Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenomics J (2007) 0.92

mPer1 and mPer2 mutant mice show regular spatial and contextual learning in standardized tests for hippocampus-dependent learning. J Neural Transm (Vienna) (2005) 0.92

The effects of methionine- and leucine-enkephalin on spinal neurones of the cat. Brain Res (1979) 0.92

Psychotoxic effects of ofloxacin. Pharmacopsychiatry (1989) 0.91